EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Vulvovaginal candidiasis and vaginal microflora interaction: Microflora changes and probiotic therapy

Zhongwen Sun, Xinnuo Ge, Bo Qiu, Ze Xiang, Chun Jiang, Jian Wu, Yuan Li

Frontiers in Cellular and Infection Microbiology · 2023

DOI: 10.3389/fcimb.2023.1123026 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Zhongwen Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Technology, Suzhou Vocational Health College, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Candidiasis, Vulvovaginal, Probiotics. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vaginal microbiome is mutually beneficial to the host and has a significant impact on health and disease. Candida species, including Candida albicans , are part of the mucosal flora of most healthy women. Under suitable conditions, they can live in the vulvovaginal mucosa, resulting in symptomatic vulvovaginal candidiasis (VVC). Based on the analysis of 16S ribosomal RNA gene sequences, great progress has been made in exploring the composition and structure of vaginal bacterial community. Moreover, researchers have conducted several studies on whether vaginal microbiome will change during VVC infection. In addition, it has been reported that vaginal colonization of probiotics in vaginal microorganisms, especially Lactobacillus , can effectively reduce the risk of VVC and treat VVC. This review aims to summarize the changes of vaginal microflora during VVC infection, and further point out the possibility of using lactic acid bacteria as probiotics to treat VVC, so as to reduce the adverse consequences of VVC infection and reduce the expensive treatment cost.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Candidiasis, VulvovaginalProbioticsFemaleHumansVaginaCandida albicansCandidaAntifungal Agents

Stichwörter der Autor:innen

Lactobacillusmicrobial changestreatmentvaginal infectionvulvovaginal candidiasis

Substanzen

Antifungal Agents

Autor:innen und Institutionen

  • Department of Medical Technology, Suzhou Vocational Health College, Suzhou, Jiangsu, China.
  • Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The…
  • Department of Clinical Laboratory, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, China.
  • Departments of Cardiology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, Jiangsu, China.

Zitieren

APA

Sun, Z., Ge, X., Qiu, B., Xiang, Z., Jiang, C., Wu, J., & Li, Y. (2023). Vulvovaginal candidiasis and vaginal microflora interaction: Microflora changes and probiotic therapy. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1123026

Vancouver

Sun Z, Ge X, Qiu B, Xiang Z, Jiang C, Wu J, et al. Vulvovaginal candidiasis and vaginal microflora interaction: Microflora changes and probiotic therapy. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1123026

BibTeX
@article{Sun2023,
  author = {Sun, Zhongwen and Ge, Xinnuo and Qiu, Bo and Xiang, Ze and Jiang, Chun and Wu, Jian and Li, Yuan},
  title = {Vulvovaginal candidiasis and vaginal microflora interaction: Microflora changes and probiotic therapy},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  doi = {10.3389/fcimb.2023.1123026}
}
Kostenlos starten →